Thank you.
As the chair, I'm going to ask a few questions, since we've gone through everyone at least once.
Mr. Clark, you mentioned some information on outreach activities that you've done in developing countries. You don't have to go through them all now, but if you have them there, can we get all the initiatives that you've taken, perhaps in written form? The CD you mentioned would be very helpful.
The second issue that I want to raise is the issue of the schedules. On page 11 of your presentation, you have “Stakeholder Positions on CAMR”, under which you say the NGOs “want immediate liberalization of the regime (eg eliminate restrictions on eligible importers and drugs...)”.
You also mentioned earlier on, on page 9, that of the other countries that have developed legislation similar to ours, “None rely on pre-approved lists of eligible importers or drugs.” I think today you said that having these schedules actually facilitates or would facilitate quicker delivery of the drugs. Can you explain why Canada has chosen to go this route, and whether it would in fact be quicker, as some have suggested, to eliminate these schedules?